Dirk Fengels
Chief Tech/Sci/R&D Officer en Sequana Medical AG .
Perfil
Dirk Fengels is currently working as the Director of Engineering & Manufacturing at Sequana Medical AG.
Previously, he worked as the Global Vice President of Engineering & Manufacturing at Sequana Medical NV from 2017 to 2020.
Mr. Fengels is a graduate of the Swiss Federal Institute of Technology.
Cargos activos de Dirk Fengels
| Empresas | Cargo | Inicio |
|---|---|---|
Sequana Medical AG
 Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Chief Tech/Sci/R&D Officer | - |
Antiguos cargos conocidos de Dirk Fengels.
| Empresas | Cargo | Fin |
|---|---|---|
| SEQUANA MEDICAL N.V. | Chief Tech/Sci/R&D Officer | 01/10/2020 |
Formación de Dirk Fengels.
| Swiss Federal Institute of Technology | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| SEQUANA MEDICAL N.V. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Sequana Medical AG
Sequana Medical AG Medical SpecialtiesHealth Technology Sequana Medical AG operates as a medical device company. It specializes in the production and design of implantable pump systems to manage fluid balance within the body. The firm offers the Alfapump system, its proprietary solution to manage and remove ascites, which can occur as a symptom of liver disease, cancer, or congestive heart failure and its focus areas encompass clinical research, product innovation, and technology development. The company was founded by Noel L. Johnson in 2000 and is headquartered in Zurich, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Dirk Fengels
